News Sentiment

NBIX sentiment intelligence

Neurocrine Biosciences Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 51 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 177.11 Week of 10 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 51

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+1.6% over one week, +10.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Zacks.com featured highlights include NVIDIA, Neurocrine Biosciences and Ball

Market Reaction

Balanced read

68/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction 1.6% Price digesting
Trend fit Trend active 10.9% over four weeks
Fair value 35.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 24
Neutral 24
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 51
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 10
Stock Titan 7
Moomoo 4
ChartMill 3
Investing.com 3
TradingView 3
simplywall.st 3
Investing.com Nigeria 2

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 9
Analyst action 5
Regulatory and legal 3
Deals and strategy 3
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-51 of 51
Investing.com Direct company coverage

Neurocrine Biosciences stock hits all-time high at 176.1 USD

Neurocrine Biosciences Inc. stock has reached an all-time high of 176.1 USD, reflecting a 35.23% increase over the past year and indicating strong investor confidence. The company's market capitalization is now $17.51 billion, with shares trading just 1% below their 52-week high.

Tone
Positive 94/100
Event
Market update
Published
07 Jul 2026 14:12
Source
Investing.com
TradingView Direct company coverage

Reasons Why Investors Should Consider Betting on Neurocrine Stock

Neurocrine Biosciences is presented as a strong investment due to the commercial success of its marketed drugs, Ingrezza and Crenessity, and a robust late-stage neuroscience pipeline with candidates like direclidine and osavampator. The recent acquisition of Soleno Therapeutics,

Tone
Neutral 50/100
Event
Deals and strategy
Published
06 Jul 2026 15:09
Source
TradingView
DirectorsTalk Interviews Direct company coverage

Neurocrine Biosciences, Inc. (NBIX): Analyst Consensus and Growth Potential with a 12% Upside

Neurocrine Biosciences (NBIX) shows strong growth potential with a 12.47% potential upside based on analyst projections. The company specializes in neurological, psychiatric, endocrine, and immunological disorders, boasting a $17.52 billion market cap, robust revenue growth, and

Tone
Positive 76/100
Event
Earnings
Published
06 Jul 2026 09:09
Source
DirectorsTalk Interviews
TradingView Direct company coverage

Enterprise value to EBIT forward of Neurocrine Biosciences, Inc. – NASDAQ:NBIX

This article provides financial information for Neurocrine Biosciences, Inc. (NASDAQ: NBIX), specifically focusing on its enterprise value to EBIT forward. It appears to be a stub or data placeholder from TradingView, offering a snapshot of financial metrics for the biotechnology

Tone
Neutral 50/100
Event
Market update
Published
04 Jul 2026 14:09
Source
TradingView
Finviz Direct company coverage

NBIX - Neurocrine Biosciences Inc Options

This article provides a detailed financial overview of Neurocrine Biosciences Inc. (NBIX), including its market performance, valuation metrics, earnings, sales data, and insider/institutional ownership. It also lists key financial ratios and stock performance across various timef

Tone
Positive 60/100
Event
Earnings
Published
04 Jul 2026 05:09
Source
Finviz